Flinton Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Flinton Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$151K	Buy	3,696 +112	+3%	+$4.84K	﹤0.01%	714
2019 Q2	$173K	Buy	3,584 +416	+13%	+$21.9K	0.01%	711
2019 Q1	$198K	Buy	3,168 +64	+2%	+$4.4K	0.01%	670
2018 Q4	$185K	Buy	3,104 +128	+4%	+$7.68K	0.01%	669
2018 Q3	$192K	Buy	2,976 +656	+28%	+$36.6K	0.01%	706
2018 Q2	$104K	Hold	2,320	–	–	﹤0.01%	761
2018 Q1	$72K	Hold	2,320	–	–	﹤0.01%	794
2017 Q4	$69K	Buy	2,320 +560	+32%	+$16.2K	﹤0.01%	796
2017 Q3	$58K	Buy	1,760 +256	+17%	+$8.87K	﹤0.01%	792
2017 Q2	$50K	Buy	1,504 +624	+71%	+$18.6K	﹤0.01%	796
2017 Q1	$26K	Buy	+880	New	+$21.8K	﹤0.01%	813

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Flinton Capital Management's BEAT Position: Q3 2019 in Review

Flinton Capital Management increased its BioTelemetry, Inc. (BEAT) stake by 3.1% in Q3 2019, buying an estimated $4.84K and bringing the position to 3,696 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Flinton Capital Management first reported a position in BEAT in Q1 2017 and has held it in 11 quarters since. The position peaked at $198K in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Flinton Capital Management held 3,696 shares of BioTelemetry, Inc. worth $151K as of Q3 2019.
Flinton Capital Management bought 112 BioTelemetry, Inc. shares in Q3 2019, an estimated $4.84K.
BioTelemetry, Inc. made up ﹤0.01% of Flinton Capital Management's portfolio in Q3 2019, its #714 holding.
Flinton Capital Management first reported a position in BioTelemetry, Inc. in Q1 2017 and has held it in 11 quarters since.
Flinton Capital Management's BioTelemetry, Inc. position peaked at $198K in Q1 2019.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.